The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogs.
Pugsley
M K
MK
Department of Pharmacology & Therapeutics, University of British Columbia, Vancouver, Canada.
Walker
M J
MJ
Garrison
G L
GL
Howard
P G
PG
Lazzara
R
R
Patterson
E
E
Penz
W P
WP
Scherlag
B J
BJ
Berlin
K D
KD
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D003331:Coronary Vessels / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D015222:Sodium Channels / Q000187:drug effects; D013034:Sparteine / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D015222:Sodium Channels; C076095:SAZ VII 6; C076096:SAZ VII 23; D013034:Sparteine; C041492:7-benzyl 3-thia-7-azabicyclo(3.3.1)nonane